Breast cancer tests vary in accuracy

Four tests used to predict if breast cancer would return 0-10 or 5-10 years after diagnosis vary in accuracy....
SEE MORE

Cancer Research UK and The Institute of Cancer Research announce partnership with Merck

New partnership aims to discover and develop new anticancer drugs....
SEE MORE

Are we one-step-closer to a universal blood test for cancer?

Researchers at John Hopkins University has trialled a method that can detect eight common forms of the disease....
SEE MORE

Researchers capture ‘incredible’ images of DNA that could help with cancer

Cyro-electron micropscopy captures RNA polymerase III....
SEE MORE

Who are The Swallows?

Find out more about our new show partner The Swallows...
SEE MORE

Patients five times more likely to avoid chemotherapy with early diagnosis

This new research is the first-time scientists have been able to show the link between the type of treatment NHS patients received and their cancer stage....
SEE MORE

Nivolumab available to hundreds of patients with head and neck cancer

The use of Nivolumab is recommended for use in the Cancer Drugs Fund (CDF) for patients with head and neck cancer who have not responded to chemotherapy within 6 months and whose cancer has spread to...
SEE MORE

New drug that can extend the life of lung cancer patients made available in Wales

An agreement between Bristol-Myers and NHS Wales will make Nivolumab available before 9th December....
SEE MORE

Positive results following trial of pembrolizumab on GI patients

Using pembrolizumab in patients who have already received treatment for metastatic gastric cancer provides optimistic results after KEYNOTE-059 trial...
SEE MORE

Researchers uncover reason behind chemotherapy failure

Researchers have identified that bacteria inside cancer cells can destroy certain drugs...
SEE MORE

Researchers identify molecule that determines if a cell will undergo cancer cell death

New research has uncovered a molecule that determines if a type of lung cancer cell will undergo cancer cell death. The discovery provides an opportunity to identify more effective methods of treatment for lung cancer patients ...
SEE MORE

OncoDNA’s solution now reimbursed in the UK

OncoSTRAT&GO is now reimbursed in the United Kingdom. OncoDNA’s most comprehensive solution analyses a solid biopsy and a liquid biopsy sample from cancer patients to predict their response to promising therapies like immunotherapies or targeted therapies. ...
SEE MORE